Testing effectiveness (Phase 2)Ended earlyNCT01191749
What this trial is testing
Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
Who this might be right for
Leukemia
M.D. Anderson Cancer Center 7